Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EOF Bio
Not specified, Delaware, United Statesecofibre.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
EOF Bio is a clinical-stage biotechnology company developing patient-centered cannabinoid-based drugs, with its lead candidate targeting endometriosis-associated pain. The company plans to initiate a Phase 2a clinical trial by the end of 2024, aiming for human proof-of-concept data in the first half of 2026. It holds an expanding portfolio of issued patents and is also exploring treatments for ovarian cancer.
- Therapeutic areas
- OncologyWomen's Health
- Modalities
- Small molecule (cannabinoid-based drugs)Biologic (if botanical extracts are considered under this umbrella, but primarily small molecule/cannabinoid)
- Industry
- Biotech
02
Partnerships
Ananda Health – manufacturing partner for clinical supplyPharmaLex – regulatory and protocol supportUniversity of Newcastle – co-developer/licensor of intellectual propertyleading global CRO contracted for trial management
Beyond the preview
Go deeper on EOF Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EOF Bio.